Serum Institute of India plans to launch Covovax by June: Adar Poonawalla
Published
SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We have applied for starting trials in India. Hope to launch Covocax by June 2021," Poonawalla said in a tweet. The new vaccine shall be launched under the brand name of Covovax, which SII is manufacturing in partnership with Novovax.
Full Article